SLGL

Sol-Gel Technologies Ltd.

0.71 USD
-0.04 (-5.33%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Sol-Gel Technologies Ltd. stock is down -21.11% since 30 days ago. The next earnings date is May 31, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 57.14% of the previous 6 May’s closed higher than April.

About Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd. focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system. Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris, Epsolay, SGT-210, and Erlotinib, Tapinarof, and roflumilast are the company's lead product candidates.